The global Bioreactors market worth by , growing at a CAGR of 17% USD 30.42 billion by 2032.
.jpg "The Global Bioreactors Market 2022-2032 (USD Billion)")
The global bioreactors market for non-food applications is valued over USD 2.6 billion in 2020. Rising investment in biotechnology & pharmaceutical sector and significant demand for stainless steel as a choice of the reactor construction material are some of the key driving bioreactors market trends.
Bioreactors Market Scope
| Metrics | Details |
| Base Year | 2023 |
| Historic Data | 2018-2022 |
| Forecast Period | 2024-2032 |
| Study Period | 2018-2032 |
| Forecast Unit | Value (USD) |
| Revenue forecast in 2032 | USD 30.42 billion |
| Growth Rate | CAGR of 17 % during 2022-2032 |
| Segment Covered | Product, Application, Cosntruction Material, Regions |
| Regions Covered | North America, Europe, Asia Pacific, South America, Middle East & Africa |
| Key Players Profiled | Sartorius AG, Merck KGaA, Thermo Fisher Scientific, Danaher Corporation, Eppendorf AG, ZETA, Infors HT, Solaris Biotech, and Spar Mixers among other |
Key Segments of the Global Bioreactors Market
Product Overview (USD Billion)
- Single-use Bioreactors
- Multi-use Bioreactors
Application Overview (USD Billion)
- Biotechnology & Pharmaceutical
- Contract Research Organizations (CROs)
- Others
Cosntruction Material Overview (USD Billion)
- Stainless Steel
- Glass
- Others
Regional Overview (USD Billion)
North America
- U.S.
- Canada
Europe
- UK
- Germany
- France
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia Pacific
South America
- Brazil
- Mexico
- Rest of South America
Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
Frequently Asked Questions (FAQ) :
The market value of cloud Bioreactors market in 2032 was USD 30.42 billion.
The bioreactors market is growing at a CAGR of 17% during the forecast period..
The Application of the bioreactors market Biotechnology & Pharmaceutical, Contract Research Organizations (CROs), Others.
Contract research organisations (CROs), biotechnology & pharmaceutical companies are among the major end-users or applications that have fueled robust bioreactor market trends. CROs are an important part of the drug development process, providing a variety of services to pharmaceutical, biotechnology, and medical device firms, as well as governments and academic institutions, and other research entities.
In CROs, single-use bioreactors are widely employed. Because CROs often handle a variety of items, it is more cost effective to use disposable bags than a stainless-steel vessel. Over the next few years, the expanding number of CROs is likely to bolster the growth of the single-use bioreactor market.
Product Segment
Product-wise, the bioreactors market is segmented into single-use and multi-use bioreactors. Single use bioreactor market is likely to increase at the fastest growth rate during the forecast period. A single-use bioreactor typically contains a disposable bag in place of a culture vessel. These products utilize a sterilized cell chamber in which the cell culture is maintained. The cell chamber reduces the cross-contamination risks as it is used for single growth operation. Furthermore, the use of single-use bioreactors optimizes the sterilization, cleaning, validation, and maintenance procedures needed for each bioreactor run.
The single use bioreactor market demand is expected to rise in pharmaceutical and R&D applications, owing to the key attributes of the product. High flexibility in terms of usage, less downtime, and controlled microbial contamination are some of the key attributes exhibited by the single-use bioreactors.
Multi-use or reusable bioreactors can be used numerous times. Reusable bioreactors require expensive and bulky clean-in-place (CIP) or steam-in-place (SIP) installations. The disposable bag of the single-use bioprocessors avoids the need to use CIP and SIP systems. The disposable bags are usually made of a three-layer plastic foil, with the layers frequently consisting of polyethylene, PVA, PVC, and polypropylene combinations to minimize leakage. The multi-use bioreactor segment accounted for more than two-third share of the global bioreactors market size in 2020.
North America dominated the global bioreactors market in 2020. It is considered to be the largest and fastest-growing consumers of the product and has contributed in increasing the global bioreactors market size, over the recent years.
.png "North America Bioreactors Market 2019-2028 (USD Billion)")
The increase in healthcare expenditure, focus on R&D for new drug development, and rising demand for drugs that treat HIV/AIDS, and cancer is expected to augment the product demand in the region, thus supporting the recent bioreactors market trends especially in the U.S. and Canada.